therapeutic autologous dendritic cells
CDR0000068481
Phase 2 mab completed
Quick answer
therapeutic autologous dendritic cells for Melanoma (Skin) is a Phase 2 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Melanoma (Skin)
- Phase
- Phase 2
- Modality
- mab
- Status
- completed